Floatz logo

Lomustine

Bone Marrow Suppression

Indiana UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Bone Marrow Suppression cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 2BB
Tazobactam
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3BB
Piperacillin
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3BB
Vancomycin
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3BB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2B

View all 27 →

Same molecule, other indications

Lomustine is also rated in:

central nervous system neoplasmDormant
BB
Indicative ·
68 / 100
View asset →
glioblastomaDormant
BB
Indicative ·
67 / 100
View asset →
diffuse large B-cell lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →